SquareMind raises $18M for Swan skin imaging robot backed by Fred Moll's Sonder Capital

· startups ai hardware · Source ↗

TLDR

  • Paris-based SquareMind raised $18M for Swan, a robot that automates full-body dermoscopic skin imaging in minutes.

Key Facts

  • The $18M includes a previously undisclosed pre-Series A; Sonder Capital led alongside France’s Deeptech 2030 Fund and others.
  • Swan captures standardized, full-body dermoscopic images contactlessly, guided by visual and audio prompts, and integrates with AI review software.
  • The robot holds a CE mark and is FDA 510(k) exempt as a Class I device; U.S. and Europe commercialization is expected in 2026.
  • SquareMind will use the funds to expand commercial, engineering, and customer support teams ahead of launch.

Why It Matters

  • Skin screening is the highest-volume dermatology procedure, but waitlists stretch months as demand outpaces capacity.
  • Automating full-body imaging could reduce documentation burden on dermatologists and support earlier detection of new lesions.

Jim Hammerand / MassDevice · 2026-04-27 · Read the original

Related coverage